Praziquantel
An antiparasitic medication used to treat a variety of parasitic worm infections, including schistosomiasis and tapeworm infections, by causing paralysis and damage to the worms so the body can eliminate them. It is typically taken as a single dose or short course and is considered highly effective against susceptible parasites.
Masse moléculaire
312,4000 g/mol
LogP
2,70
TPSA
40,60 Ų
Règle des 5 de Lipinski
Conforme
Aires thérapeutiques
Mécanisme d'action
Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.
Structure 2D
Cite this structure
Embed this structure
SMILES
O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1
InChI
InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2
Molecular Formula
C19H24N2O2
HBD / HBA
- / 2
Liaisons Rotatives
1
Atomes Lourds
23
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Foire aux questions
An antiparasitic medication used to treat a variety of parasitic worm infections, including schistosomiasis and tapeworm infections, by causing paralysis and damage to the worms so the body can eliminate them. It is typically taken as a single dose or short course and is considered highly effective against susceptible parasites.
Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.
Yes, Praziquantel is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL976. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 4891. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="praziquantel"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/praziquantel/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/praziquantel/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/praziquantel/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="praziquantel"></drugfyi-drug>